BroadOak Leads Acquisition of Particle Dynamics from Edgewater Capital Partners
September 29, 2021
Particle Dynamics, a U.S.-based specialist in particle processing and finished-dose manufacturing for pharmaceutical, OTC and nutraceutical customers, was sold by Edgewater Capital Partners to a new investor group led by BroadOak Capital Partners with Research Corporation Technologies and Farragut Capital Partners. The transaction (announced September 29, 2021) creates a new ownership group that aims to accelerate the company’s growth and expand its capabilities at its U.S. GMP, FDA-inspected facilities.
- Buyers
- BroadOak Capital Partners, Research Corporation Technologies, Farragut Capital Partners
- Targets
- Particle Dynamics
- Sellers
- Edgewater Capital Partners
- Industry
- Healthcare Services
- Location
- Missouri, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Farragut Capital Partners and BroadOak Invest in Particle Dynamics
November 19, 2019
Pharmaceuticals
Farragut Capital Partners led a growth investment in Particle Dynamics, Inc., joined by BroadOak Capital Partners; Particle Dynamics is a portfolio company of Edgewater Capital Partners. The capital will support the company's growth and capability expansion across its particle processing, microencapsulation and finished-dosage manufacturing services operating from FDA‑inspected facilities in St. Louis, Missouri and Seymour, Indiana.
-
BroadOak Invests in Microsize (Lonza's North American Micronization Business)
July 1, 2022
Pharmaceuticals
BroadOak Capital Partners led an investor-backed launch of Microsize after acquiring Lonza’s North American micronization business in Quakertown, Pennsylvania. The newly independent CDMO — operating three facilities and focused on micronization and particle-size control for APIs and excipients — will be run by industry veterans including Chairman Derek Hennecke and CEO TJ Higley to expand US-based API solubility and bioavailability enhancement capabilities.
-
Particle Dynamics Acquires EUROAPI UK Haverhill Spray Drying Facility
June 30, 2025
Pharmaceuticals
Particle Dynamics has acquired EUROAPI UK Ltd., the operator of a commercial spray drying facility in Haverhill, United Kingdom, from EUROAPI as part of the latter’s portfolio restructuring. The deal adds spray-drying expertise and commercial-scale capacity to Particle Dynamics’ global CDMO platform and will see investment to expand capabilities and serve clinical and commercial projects.
-
Edgewater Capital Partners Acquires GL CHEMTEC
August 11, 2022
Pharmaceuticals
Edgewater Capital Partners, a Cleveland-based lower middle-market private equity firm, has acquired GL CHEMTEC, a chemistry-based contract research organization (CRO) headquartered in Oakville, Ontario. Edgewater will support GLC's expansion of API development, scale-up and advanced materials capabilities to accelerate growth across North American pharma and life-sciences customers.
-
BroadOak Capital Partners and RCT Invest in Biolog, Inc.
May 12, 2022
Biotechnology
BroadOak Capital Partners and Research Corporation Technologies (RCT) made a growth capital investment in Biolog, Inc., a Hayward, California-based provider of cell-based microbial identification and phenotypic profiling technologies. As part of the recapitalization, Robert Wicke was named CEO and the company will use proceeds to advance its cellular analysis product portfolio and expand commercial adoption across pharmaceutical, academic, biotech and environmental markets.
-
cleanwater1 Acquires Velocity Dynamics, LLC
January 3, 2024
Environmental Services
cleanwater1 (formerly UGSI Solutions), a Baird Capital portfolio company, has acquired Velocity Dynamics, LLC, a provider of proprietary dry and liquid feed systems for chemistry optimization in water/wastewater utilities and industrial plants. The deal expands cleanwater1’s product and engineering capabilities in polymer blending, chemical feed and bulk handling to support customers facing higher chemical costs and stricter environmental requirements.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.